Has David Polly, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,308,167 in general payments to David Polly, MD across 1,279 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Polly, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Polly, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Polly, MD

Orthopaedic Surgery · Minneapolis, MNNPI 1669483046

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (57.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Si-bone, Inc. accounts for 93.3% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $1,060,521, more than ten times the $68,397 reported in 2019. Among orthopaedic surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,308,167in general payments, 2019–2025

Across 1,279 payments — averaging $2586.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Si-bone, Inc.$3.1M
Medtronic$169K
Globus Medical$50K
Alphatec Spine, Inc$448
Pacira Pharmaceuticals Incorporated$204
Carlsmed, Inc.$160
plus $706 from 7 others

$111,983in research payments, 2019–2025

Across 12 payments — averaging $9331.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$112K

What the payments were for

Royalty or licence$1,904,51258%
Consulting fees$1,268,60538%
Speaking & faculty fees$17,1501%
Travel & lodging$94,9793%
Food & beverage$22,9211%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Si-bone, Inc.	1,048	$3,087,516
Medtronic(2 entities)	188	$169,129
Globus Medical(2 entities)	30	$50,004
Alphatec Spine, Inc	2	$448
Pacira Pharmaceuticals Incorporated	2	$204
Carlsmed, Inc.	1	$160
Medical Device Business Services, Inc.	1	$143
Johnson & Johnson	1	$125
Zimmer Biomet	1	$123
Stryker	1	$115
Kuros Biosciences USA, Inc	1	$95
Orthofix Medical, Inc.	2	$55
Choice Spine, LLC	1	$50

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

IFUSE IMPLANT SYSTEM$2,229,084
iFuse Implant$834,162
UNID_PASS$73,421
CREO$28,999
CATALYFT PL EXPANDABLE INTERBODY SYSTEM$26,675
O-ARM$15,665
MIS Screw System$9,750
MAZOR X SYSTEM$2,169
CALIBER$1,138
EXTERNAL FIXATION$624
Excelsius - GPS$559
CardioInsight$550
Other - Miscellaneous$448
Mazor X Stealth Edition$277
CD HORIZON SPINAL SYSTEM$268
GRAFTONAND GRAFTON PLUSDEMINERALIZED BONE MATRIX (DBM)$179
CREO 5.5$164
aprevo$160
CONDUIT$143
VIPER$125

How this compares

$3,308,167 in reported general payments places this provider in the 95th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024

$84,024

Medicare patients

Services billed

259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	22	$324

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Minneapolis

Ensor TransfeldtMinneapolis$2.3M
Manuel PintoMinneapolis$1.7M
Joseph PerraMinneapolis$1.6M
Timothy GarveyMinneapolis$1.6M
Amir MehbodMinneapolis$1.3M
David TemplemanMinneapolis$361K
Patrick YoonMinneapolis$203K
Christopher MartinMinneapolis$131K
Elizabeth ArendtMinneapolis$111K
Emily WagstromMinneapolis$71K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →